Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Pandemic Has Left Nearly 43 Million Americans Without WorkPeople Are Avoiding the ER During COVID-19 Crisis at Their Peril: StudyAs Postponed Surgeries Resume, Can U.S. Hospitals Handle the Strain?Most Americans Still More Worried About COVID-19 Spread Than the EconomyBig Need for Blood Donations as Postponed Surgeries ResumeEmergency Transport Can Surprise Many With Big BillsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyIf Prescribed Opioids for Pain, Ask Lots of Questions: FDAState Texting Bans Are Saving Teen Drivers' LivesMillions of Older Americans Can't Get Enough FoodLayoffs and Losses: COVID-19 Leaves U.S. Hospitals in Financial CrisisFDA Goes After Unproven COVID-19 Antibody TestsDuring Droughts, Many Poor Americans Will Lack Clean Tap Water: StudyDid the Movie 'Joker' Reinforce Prejudice Against Mentally Ill?AHA News: How to Get the Most Out of Health AppsCoronavirus Conspiracy Theories Abound, and They Could Cause Real HarmAHA News: Health Emergency? Don't Hesitate to Get HelpAn Expert's Guide to Fact-Checking Coronavirus Info OnlineRacial, Ethnic Gaps in Insurance Put Moms, Babies at Risk: StudyCelebrity Suicides Spawn 'Copycat' Tragedies, Study Shows
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort">
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort
The Doctor Gap: Where Are All the Mental Health Care Providers?New, Graphic Health Warnings Coming for U.S. Cigarette PacksWith New Boost From Medicare, 'Telemedicine' Steps Up to Fight CoronavirusThe Doctor Gap: In Rural America, It's All Hands on DeckThe Doctor Gap: A Training Program for Country-Doc WannabesDon't Believe All the 'Science' on CBD ProductsMany Car Crash Deaths Involve Alcohol Levels Below Legal Limit: StudyThe Doctor Gap: Does America Have a Physician Shortage?12 Weeks of Paid Maternity Leave Benefits Everyone: StudyVaping Videos Soaring on YouTubeU.S. Blood Donors Needed in Face of COVID-19 CrisisIt's Tough for Clinical Trial Participants to Learn ResultsBogus Coronavirus 'Meds' Targeted by FDAOnly 1 in 5 Have Fast Access to State-of-the-Art Stroke CareOne Key Way to Curb Coronavirus Spread: More Paid Sick LeaveU.S. Drug Prices Have Risen Three Times Faster Than InflationU.S. Announces More Travel Restrictions as First Coronavirus Death ReportedIt's Not Medical Outcomes That Drive Patients' Hospital ReviewsChicago's Short-Lived 'Soda Tax' Cut Consumption, Boosted Health Care FundsSocial Media Stokes Myths About VaccinesBrand-Name Rx Rise After Docs Get Drug Company Perks: StudyAs Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go WithoutRoll Up Your Sleeve and Donate Blood for Cancer PatientsShotguns Often Play Tragic Role in Rural Teens' Suicides: StudyPrice Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersConsumers Waste Twice as Much Food as Experts ThoughtStricter Clean Air Laws Could Save Thousands of Lives a Year: StudyCaregivers Give Short Shrift to Their Own HealthMedicare Could Save Billions If Allowed to Negotiate Insulin Prices
Links
Related Topics

Health Insurance
Healthcare

FDA Goes After Unproven COVID-19 Antibody Tests

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: May 4th 2020

new article illustration

MONDAY, May 4, 2020 (HealthDay News) -- The U.S. Food and Drug Administration said Monday it will crack down on the fraudulent COVID-19 antibody tests that have flooded the market.

Companies selling coronavirus antibody tests will be required to submit data proving accuracy within the next 10 days, or their products could be yanked from public circulation, FDA officials said.

Since mid-March, dozens of manufacturers have been allowed to sell antibody tests without providing any evidence they are accurate, under the initial policy announced by the FDA.

The intent of the initial policy was to support "the availability of antibody tests, which are an important tool in our fight against the coronavirus," FDA Commissioner Dr. Stephen Hahn explained during a media briefing.

Unfortunately, many of the tests that came onto the market simply aren't accurate.

A recent assessment of 14 coronavirus antibody tests now available to consumers revealed that only three delivered consistently reliable results, according a report issued by a team of more than 50 scientists.

Many antibody tests are also being falsely advertised or inappropriately marketed, said Dr. Jeff Shuren, director of the FDA's Center for Devices and Radiological Health.

"Many companies are marketing them for use at home," Shuren said. "That was never permitted under our policy, unless authorized by the FDA."

Others are falsely claiming that their tests are FDA-approved for accuracy, or that the antibody test can be used to diagnose an active case of COVID-19, the agency said.

Antibody tests only can say whether a person has been exposed to the new coronavirus. A viral test to check for the presence of coronavirus in a person's blood or mucous is the only way to detect active infection.

The FDA also stepped in to halt the import of bad test kits from other countries, Shuren said.

"Flexibility never meant we would allow fraud," Shuren said in an FDA release co-authored by Dr. Anand Shah, the FDA's deputy commissioner for medical and scientific affairs. "We unfortunately see unscrupulous actors marketing fraudulent test kits and using the pandemic as an opportunity to take advantage of Americans' anxiety," Shuren noted.

Under the new policy, the FDA will provide manufacturers and laboratories with guidelines for gathering the accuracy data needed to acquire an Emergency Use Authorization (EUA).

All companies with an antibody test currently on the market will need to get an EUA. "Our expectation is that those who can't do that will remove their product from the market, and we will be working with them to help them do that," Hahn said.

To date, 12 antibody tests have been issued an EUA, including two developed by high-level diagnostic laboratories, Hahn said.

There are more than 250 antibody tests currently being reviewed by the FDA for an EUA, Hahn added.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net